National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/26/2021 release of VAERS data:

Found 2,908 cases where Vaccine is COVID19 and Symptom is COVID-19 and Patient Died

Government Disclaimer on use of this data



Case Details (Sorted by Age)

This is page 14 out of 291

Result pages: prev   5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23   next


VAERS ID: 1048275 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-12-31
Onset:2021-01-01
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6797 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Death, SARS-CoV-2 test
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-10
   Days after onset: 9
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Exposure to COVID-19; General physical health deterioration; Living in nursing home
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 202101; Test Name: COVID-19 virus test; Test Result: Positive
CDC Split Type: DKPFIZER INC2021158626

Write-up: Death. It is not inconceivable that the total liability of Covid-19 disease and the vaccination has been fatal for the patient; COVID-19; This is a spontaneous report from a contactable physician. This is a report received from the Medicines Agency (MA) Regulatory Authority-WEB. Regulatory authority number DK-DKMA-WBS-0032146. Safety Report Unique Identifier DK-DKMA-ADR 24693314. An 86-year-old male patient received the first dose of bnt162b2 (COMIRNATY), batch/lot number: ej6797, intramuscularly on 31Dec2020 at single dose for covid-19 immunisation. Medical history included ongoing general physical health deterioration, and the patient was living in nursing home where there was a covid-19 outbreak among several residents and staff (concurrent condition). There was no information regarding concomitant medication and past medication. On 10Jan2021 the patient died. Reported cause of death was death and of/with COVID-19. Only normal confirmation of death was performed post mortem. No findings were reported. An autopsy was not performed. The adverse drug reactions (ADRs) were by the physician reported as fatal. No treatment due to the ADRs was reported. The patient underwent lab tests which included Covid-19 virus test in Jan2021, positive. About causality, the physician stated that It is not inconceivable that the total liability of Covid-19 disease and the vaccination has been fatal for the patient. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Death. It is not inconceivable that the total liability of Covid-19 disease and the vaccination has been fatal for the patient; COVID-19


VAERS ID: 1048276 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2020-12-31
Onset:2021-01-13
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6797 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Death, SARS-CoV-2 test
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-13
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: COVID-19; General physical health deterioration; Living in nursing home (there was a covid-19 outbreak among several residents and staff)
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 202101; Test Name: COVID-19 virus test; Test Result: Positive
CDC Split Type: DKPFIZER INC2021158625

Write-up: Covid-19; Death. It is not inconceivable that the total liability of Covid-19 disease and the vaccination has been fatal for the patient.; This is a spontaneous report downloaded from the Regulatory Authority-WEB DK-DKMA-ADR 24693323. The case was received from a contactable physician via The Agency. A 92-year-old female patient received the first dose of bnt162b2 (COMIRNATY, Lot number: ej6797, expiration date: 30Apr2021) intramuscular on 31Dec2020 at single dose for covid-19 immunisation. Medical history included patient concurrent conditions included Covid-19 and general physical health deterioration and Living in nursing home in which there was a covid-19 outbreak among several residents and staff. Concomitant medications were not provided. The patient was death on 13Jan2021, which the reporting physician described the occurrence of death, it is not inconceivable that the total liability of Covid-19 disease and the vaccination has been fatal for the patient, in a 92 years old female patient vaccinated with bnt162b2. Reported cause(es) of death: Death and of/with COVID-19. Only normal confirmation of death was performed post mortem. The patient underwent lab tests and procedures, which included Covid-19 test on Jan2021 as positive. The patient died on 13Jan2021. An autopsy was not performed and the reported cause of death was death and COVID-19. Causality from the reporter: it was not inconceivable that the total liability of Covid-19 disease and the vaccination has been fatal for the patient. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: COVID-19; Death


VAERS ID: 1048282 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-05
Onset:2021-01-19
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-09
   Days after onset: 21
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Chronic renal failure; Dementia Alzheimer''s type
Preexisting Conditions: Medical History/Concurrent Conditions: Fibrillation atrial
Allergies:
Diagnostic Lab Data: Test Date: 20210119; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:positive
CDC Split Type: ESPFIZER INC2021169112

Write-up: COVID-19; COVID-19; This is a spontaneous report downloaded from the Medicines Agency (MA) Regulatory Authority-Web [Regulatory Authority number ES-AEMPS-746451] from a contactable consumer. A 99-year-old female patient received the 1st dose of bnt162b2 (COMIRNATY), via an unspecified route of administration in the arm, on 05Jan2021, at single dose, for COVID-19 immunisation. Medical history included ongoing chronic kidney disease, ongoing dementia Alzheimer''s type and atrial fibrillation. Concomitant medications were not reported. The patient experienced COVID-19 on 19Jan2021. The patient presented symptoms and was hospitalized due to the event from 01Feb2021. The patient underwent lab tests and procedures which included COVID-19 virus test: positive on 19Jan2021. The patient died on 09Feb2021 due to the event. An autopsy was not performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: COVID-19; COVID-19


VAERS ID: 1048309 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-29
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6788 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, SARS-CoV-2 test
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-06
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Living in nursing home
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210203; Test Name: COVID-19 virus test; Test Result: Positive
CDC Split Type: FRPFIZER INC2021169148

Write-up: COVID-19 aggravated; This is a spontaneous report from a contactable consumer reporting on behalf of the father and downloaded from the Agency Regulatory Authority-WEB (Regulatory Authority number FR-AFSSAPS-NC20210377). A 94 years old male patient received the first single dose of BNT162B2 (COMIRNATY; lot EJ6788) intramuscular, on 29Jan2021, for COVID-19 immunisation. The patient was resident at the nursing home. Other medical history and concomitant medications were not reported. The anti-COVID vaccine was administered to the patient at the nursing home on 29Jan2021. Following 1 positive case of COVID detected in the nursing home, the residents were confined to their rooms from 30Jan2021. The patient tested positive for COVID on 03Feb2021, as well as 2 other residents of the residence. His state of health quickly deteriorated and he died on 06Feb2021 in the nursing home due to COVID-19 aggravated. It was unknown if an autopsy was done. The pharmacovigilant notes: accountability score(s) established without prejudice to the elements of investigation which could be carried out within the framework of legal or amicable compensation procedures. Official Bulletin of the Minister in charge of Health. No follow-up attempts are possible, no information is expected.; Reported Cause(s) of Death: COVID-19 aggravated


VAERS ID: 1048324 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-21
Onset:2021-02-03
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6788 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Blood pressure measurement, Body temperature, COVID-19, Drug ineffective, Haemoglobin, Heart rate, International normalised ratio, Oxygen saturation, Platelet count, SARS-CoV-2 test, Spinal X-ray, White blood cell count
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-03
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: COUMADINE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arteriopathic disease; Atrial fibrillation; Cardiac arrhythmia; Chronic cor pulmonale; COPD; Dementia aggravated; Dementia with Lewy bodies; Hernia hiatal; Hyperthermia (hyperthermia and sudden desaturation); Oxygen saturation decreased (hyperthermia and sudden desaturation); Thromboendarterectomy (Bilateral pulmonary thromboendarterectomy); Thyroidectomy; Ulcer
Allergies:
Diagnostic Lab Data: Test Date: 20210203; Test Name: BP; Result Unstructured Data: Test Result:retained; Test Date: 20210121; Test Name: body temperature; Result Unstructured Data: Test Result:36.5 Centigrade; Test Date: 20210203; Test Name: body temperature; Result Unstructured Data: Test Result:38.7 Centigrade; Test Date: 20210126; Test Name: haemoglobin; Result Unstructured Data: Test Result:16.4 g/dl; Test Date: 20210203; Test Name: pulse; Result Unstructured Data: Test Result:Rapid pulse +++; Test Date: 20210123; Test Name: international normalized ratio; Result Unstructured Data: Test Result:2.9; Test Date: 20210126; Test Name: international normalized ratio; Result Unstructured Data: Test Result:New rise in INR; Comments: New rise in INR despite reduction in dose of COUMADINE.; Test Date: 20210129; Test Name: international normalized ratio; Result Unstructured Data: Test Result:1.7; Test Date: 20210202; Test Name: international normalized ratio; Result Unstructured Data: Test Result:1.7; Test Date: 20210203; Test Name: oxygen saturation; Result Unstructured Data: Test Result:below 70 %; Test Date: 20210126; Test Name: platelets; Result Unstructured Data: Test Result:277 x10 9/l; Test Date: 20201231; Test Name: PCR COVID-19 test; Test Result: Negative ; Test Date: 20210203; Test Name: PCR COVID-19 test; Test Result: Positive ; Test Date: 20210126; Test Name: sacro-coccygeal abscess; Result Unstructured Data: Test Result:sacro-coccygeal abscess; Test Date: 20210126; Test Name: leucocyte; Result Unstructured Data: Test Result:8.7 x10 9/l
CDC Split Type: FRPFIZER INC2021164512

Write-up: COVID-19 infection; COVID-19 infection; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency (MA) Regulatory Authority -WEB regulatory authority FR-AFSSAPS-RS20210172. A 73-year-old female patient received the first dose bnt162b2 (COMIRNATY, lot number: EJ6788), intramuscular on 21Jan2021 at SINGLE DOSE for covid-19 immunisation. Medical history included Cardiac arrhythmia, Dementia with Lewy bodies, Atrial fibrillation, COPD, Ulcer, Chronic cor pulmonale, Thyroidectomy, Arteriopathic disease, Hernia hiatal, all from unknown date and unknown of ongoing, Bilateral pulmonary thromboendarterectomy in 2000, severe dementia from Oct2020, hyperthermia and sudden desaturation from 31Dec2020. Concomitant medication included warfarin sodium (COUMADINE). The patient previously received clozapine (LEPONEX) for dementia, ceftriaxone sodium (ROCEPHINE), amoxicillin clavulanic acid (AUGMENTIN), and ofloxacin. The patient experienced COVID-19 infection on 03Feb2021 with outcome of fatal. Clinical course: In Oct2020, the patient presented psychotic symptoms of severe dementia. Introduction of clozapine. 31Dec2020: episode of hyperthermia and sudden desaturation. PCR COVID negative. Treatment with ceftriaxone sodium in probabilistic mode. Switch ceftriaxone sodium to amoxicillin clavulanic acid + ofloxacin for cutaneous + urinary tract. 14Jan2021: seat lesion on the way to healing but widening of the orifice of the lesion which is flush with the anus. 21Jan2021: vaccination with bnt162b2. Apyretic patient at 36.5 deg C before injection. No reaction 15 minutes after injection. Patient under warfarin sodium (COUMADINE) (not administered on 20Jan2021 in the evening). Long compression at the injection site, no hematoma. Medical observations following vaccination: 23Jan2021: INR 2.9 check. 26Jan2021: biologically: Hb 16, 4 g / dL; Leuco 8.7 G / L; platelets 277 G / L. New rise in INR despite reduction in dose of warfarin sodium, new warfarin sodium treatment regimen. Hemoconcentration, it is recommended that the patient drink well. 29Jan2021 and 02Feb2021: INR 1.7. 03Feb2021: occurrence of acute asphyxial febrile respiratory distress on massive PAO, call from the IDE for acute dyspnea with desaturation below 70 percent. Fever at 38.7 deg C. Stage IV dyspnea. Rales diffuse in the 2 pulmonary fields. No edema of the MIG. Rapid pulse +++ BP retained. 03Feb2021: SARS-Cov2 RT-PCR positive. COVID 19 infection GD. Poor short-term prognosis. Part of cardiac decompensation on AC / AF rapid. The patient died on 03Feb2021 at 5:15 p.m. It was not reported if an autopsy was performed.; Reported Cause(s) of Death: COVID-19 infection; COVID-19 infection


VAERS ID: 1048327 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-05
Onset:2021-01-11
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Cardiac failure, Disease recurrence, Drug ineffective, Dyspnoea, Haemodynamic instability, Hypoxia, Lung disorder, Pneumonia, Respiratory distress, SARS-CoV-2 test
SMQs:, Cardiac failure (narrow), Anaphylactic reaction (broad), Asthma/bronchospasm (broad), Lack of efficacy/effect (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypersensitivity (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-23
   Days after onset: 12
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: AFib; Anxiety; Cardiomyopathy; Chronic renal failure; Cognitive disturbance; Decompensation cardiac; Depression; Hyperthyroidism; Insulin-requiring type II diabetes mellitus
Allergies:
Diagnostic Lab Data: Test Date: 20210117; Test Name: antigenic Covid test; Test Result: Negative ; Test Date: 20210121; Test Name: antigenic Covid test; Test Result: Negative ; Test Date: 20210121; Test Name: Covid PCR test; Test Result: Positive
CDC Split Type: FRPFIZER INC2021159197

Write-up: 2019 novel coronavirus infection; Covid PCR test: positive; Pneumopathy; Dyspnoea; Hypoxia; worsening of the respiratory state, respiratory distress; hemodynamic instability; appearance of signs of cardiac decompensation; appearance of signs of cardiac decompensation; left basal pneumonia treated with antibiotics; This is a spontaneous report from a contactable pharmacist downloaded from the Medicines Agency (MA) Regulatory Authority-WEB FR-AFSSAPS-ST20210155. A 90-year-old female patient received first dose of bnt162b2 (COMIRNATY, lot/batch number and expiry date unknown), intramuscular on 05Jan2021 at unknown age at 0.3 mL single dose for covid-19 immunization. Medical history included atrial fibrillation, Cognitive disturbance, insulin-requiring type 2 diabetes mellitus, hyperthyroidism, anxiety, Chronic renal failure, Decompensation cardiac, depression, and cardiomyopathy, all from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. The patient experienced pneumopathy on 15Jan2021. On 11Jan2021, the patient had evidence of dyspnea with moderate hypoxia. On 15Jan2021, the patient had evidence of left basal pneumonia treated with antibiotics. On 17Jan2021, the patient performed an antigenic covid test with negative result. On 20Jan2021, the patient had worsening of the respiratory state with appearance of signs of cardiac decompensation. On 21Jan2021, the patient carried out of a new antigenic Covid test with negative result and Covid PCR test with positive test. On 22Jan2021, the patient was worsening of the respiratory state, respiratory distress and hemodynamic instability. The patient had comfort care in the service. The patient died on 23Jan2021. Seriousness criteria provided for hypoxia, pneumopathy, dyspnea, 2019 novel coronavirus infection and Covid PCR test with positive test was hospitalization and death. The reporter considered the picture of concomitant COVID-19 infection to be worsened by vaccination. The patient died for hypoxia, pneumopathy, dyspnea, 2019 novel coronavirus infection and Covid PCR test with positive test on 23Jan2021. An autopsy was not performed. Outcome of other events were unknown. No follow-up attempts are possible. No further information expected. Information on batch/lot number can not be obtained.; Reported Cause(s) of Death: dyspnea; hypoxia; Pneumopathy; 2019 novel coronavirus infection; covid pcr test: positive


VAERS ID: 1048387 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2020-12-23
Onset:2020-12-23
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, COVID-19 pneumonia, Drug ineffective, SARS-CoV-2 test, Sepsis
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (narrow), Sepsis (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-06
   Days after onset: 45
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210202; Test Name: COVID-19 PCR test; Test Result: Positive ; Test Date: 20201215; Test Name: COVID-19 virus test; Test Result: Negative
CDC Split Type: GBPFIZER INC2021170192

Write-up: Viral pneumonia; SARS-CoV-2 infection; SARS-CoV-2 infection; Sepsis; This is a spontaneous report from a contactable consumer, received from the MHRA. Regulatory authority report number GB-MHRA-WEBCOVID-202102121609242860, Safety Report Unique Identifier GB-MHRA-ADR 24750893. An 87-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 23Dec2020 at single dose for covid-19 immunisation, on release from hospital. The patient medical history and the patient''s concomitant medications were not reported. Patient has not had symptoms associated with COVID-19. Patient was not enrolled in clinical trial. The patient felt at home on 24Dec2020 and was hospitalized. She was discovered to have sepsis, occurred on 23Dec2020. She improved and was released to a care home on 06Jan2021. She had a COVID-19 PCR test performed with a positive result on 02Feb2021 and shortly after was rushed to hospital. She was diagnosed with viral pneumonia and died on 06Feb2021 of viral pneumonia. It was not reported if an autopsy was performed. The patient underwent lab test included a sars-cov-2 test: negative on 15Dec2020. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Viral pneumonia


VAERS ID: 1048390 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-14
Onset:2021-01-24
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Acute kidney injury, COVID-19, Confusional state, Drug ineffective, Electroencephalogram, Encephalopathy, Hallucination, Hypertonia, Myoclonus, SARS-CoV-2 test, Seizure, Tremor
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Lack of efficacy/effect (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Dementia (broad), Convulsions (narrow), Parkinson-like events (narrow), Psychosis and psychotic disorders (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (narrow), Noninfectious meningitis (broad), Generalised convulsive seizures following immunisation (narrow), Chronic kidney disease (broad), Tumour lysis syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (broad), Dehydration (broad), Hypokalaemia (broad), Opportunistic infections (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-12
   Days after onset: 19
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: AMLODIPINE; ATORVASTATIN; BISOPROLOL; COLECALCIFEROL; EDOXABAN; FAMOTIDINE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Chronic kidney disease; Gingival hypertrophy; Hepatic steatosis; Hypertension; Ischaemic stroke; Pulmonary embolism; Pulmonary sarcoidosis; Sensorineural hearing loss
Allergies:
Diagnostic Lab Data: Test Name: EEG; Result Unstructured Data: Test Result:showed general slowing, nil specific; Test Date: 20210131; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Positive COVID-19 test; Test Date: 20210206; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:suspected positive
CDC Split Type: GBPFIZER INC2021170185

Write-up: confusion; hallucinations; increased tone in arms; tremor; myoclonic jerks; Acute kidney injury; Seizures; Drug ineffective; SARS-CoV-2 infection; Encephalopathy acute; This is a spontaneous report from a contactable physician, received from the regulatory authority. Regulatory authority report number GB-MHRA-WEBCOVID-202102151314380170 , Safety Report Unique Identifier GB-MHRA-ADR 24765082. A 85-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 14Jan2021 at single dose for covid-19 immunisation. Medical history included deafness neurosensory, pulmonary embolism, ischaemic stroke, gingival hypertrophy, hypertension, chronic kidney disease, stage 2 pulmonary sarcoid and liver steatosis, all unknown if ongoing. Concomitant medications included amlodipine, atorvastatin, bisoprolol, colecalciferol, edoxaban, famotidine. The patient experienced encephalopathy acute on 24Jan2021 and was admitted to hospital on 27Jan2021 with few days history of confusion and hallucinations, tremor, increased tone in arms. Also had Acute kidney injury (resolved in days with treatment). Developed myoclonic jerks and then seizures on 01Feb2021. Tested positive for covid around a week into admission on 31Jan2021. Lab data included a suspected covid-19 infection on 06Feb2021. Neurology opinion sought - unable to perform LP due to agitations and seizures, too unwell by the time CEPOD available. MRI unable to do due to covid and then deterioration. EEG showed general slowing, nil specific. Treated with intravenous acyclovir and ceftriaxone empirically (possible infective cause). Loaded on levetiracetam. Deteriorating level of consciousness throughout admission. Started on steroids, however, went to palliative care on 12Feb2021. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: drug ineffective; confusion; hallucination; hypertonia; tremor; myoclonus; seizure; covid-19; encephalopathy


VAERS ID: 1048391 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-09
Onset:2021-01-23
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ1688 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Death, Drug ineffective, Malaise, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-02-13
   Days after onset: 21
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: CITALOPRAM; OLANZAPINE; PREGABALIN; TEGRETOL RETARD
Current Illness: Exposure to COVID-19
Preexisting Conditions: Medical History/Concurrent Conditions: Behavioural disorder; Learning disorder (Severe learning difficulties with self-harm); Low mood
Allergies:
Diagnostic Lab Data: Test Date: 20210123; Test Name: COVID-19 virus test; Test Result: Positive
CDC Split Type: GBPFIZER INC2021170024

Write-up: unwell; Death NOS; sars-cov-2 infection; sars-cov-2 infection; This is a spontaneous report from a contactable healthcare professional received from the Medicines and Healthcare products Regulatory Agency (MHRA). Regulatory authority report number GB-MHRA-WEBCOVID-202102151354130980, Safety Report Unique Identifier GB-MHRA-ADR 24765674. A 53-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot EJ1688), via an unspecified route of administration on 09Jan2021 at single dose for covid-19 immunisation. Medical history included learning disorder from an unknown date and unknown if ongoing reported as severe learning difficulties with self-harm, low mood and behavioural disorder. Patient was not enrolled in clinical trial. Concomitant medication included citalopram (unknown manufacturer), olanzapine (unknown manufacturer), pregabalin (unknown manufacturer), carbamazepine (TEGRETOL RETARD). The patient experienced death nos on 13Feb2021. The patient experienced also unwell on an unspecified date with outcome of recovered and sars-cov-2 infection on 23Jan2021 with outcome of unknown. The events were life-threatening. The patient underwent lab tests and procedures which included positive covid-19 test on 23Jan2021. The patient died on 13Feb2021. An autopsy was not performed. The events were reported as mild non specific malaise. Contact with carrier positive so screened and found positive. Not acutely unwell when went to bed, found dead in morning of 13Feb2021. No follow-up attempts are possible. No further information expected.; Reported Cause(s) of Death: Death NOS


VAERS ID: 1048626 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-19
Onset:2021-01-25
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Cardio-respiratory arrest, SARS-CoV-2 test
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Respiratory failure (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-29
   Days after onset: 4
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ESOMEPRAZOLE; FUROSEMIDE; CLOPIDOGREL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Gastric ulcer; Melanoma; Penicillin allergy; Pneumonia; Stroke
Allergies:
Diagnostic Lab Data: Test Name: COVID-19 virus test; Test Result: Negative
CDC Split Type: PTPFIZER INC2021163772

Write-up: Cardio-respiratory arrest; conclusion that she caught Covid and the vaccine did not protect her/ extreme tiredness/ a slight cough/ a fever; This is as spontaneous report received from a contactable consumer downloaded from the Medicine Agency (MA) Regulatory Authority-WEB. The regulatory authority report number is PT-INFARMED-T202102-951. A contactable consumer reported that a 92-years-old female patient received 1st dose of bnt162b2 (COMIRNATY), intramuscular on 19Jan2021 at 0.3 mL single for covid-19 immunisation. There was reference to clinical history in the past of melanoma, stroke, gastric ulcer, pneumonia and unknown if ongoing. There was a history of allergy to penicillin. Concomitant medication included esomeprazole, furosemide, clopidogrel. The adverse reaction, appeared about 6 days after the administration of the first dose of the suspected drug (25Jan2021), and was initially characterized by extreme tiredness that led her to eat in the bedroom and a slight cough. After 9 days of inoculation, a fever developed. The patient died on the 10th day (29Jan2021). The conclusion was that the patient caught COVID and the vaccine did not protect her associated with the use of bnt162b2 against COVID-19 (with modified nucleoside), 30 mcg/0.3 ml, concentrate for dispersion for injection, in 1st dose, for active immunization to prevent COVID-19 caused by the SARS-CoV virus-2, with the dosage of 2 intramuscular doses (0.3 ml each) with an interval of at least 21 days between each dose. The patient was not previously infected with the SARS-CoV-2 virus, according to the notifier, the patient was institutionalized and everyone tested Covid, they were confined to their rooms, the test result was negative. The patient died of cardiorespiratory arrest. No autopsy was performed. There was no concrete diagnosis of Covid infection, the notifier said in funeral homes say they would be treated as a suspect for Covid and, according to information from the institution, they were also hit hard by this plague. Evolution of adverse reaction was death. There was no reduction in dosage. The suspected drug was suspended once the vaccination schedule was incomplete, and the second dose was not administered. There was no suspicion of interaction between drugs. There is no information on the specific treatment of the reaction. The events outcome was fatal. No follow-up attempts are possible, information about batch number cannot be obtained.; Reported Cause(s) of Death: conclusion that she caught Covid and the vaccine did not protect her/ extreme tiredness/ a slight cough/ a fever; Cardio-respiratory arrest


Result pages: prev   5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=14&ESORT=AGE&SYMPTOMS=COVID-19&VAX=COVID19&DIED=Yes


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166